Study unveils mechanisms behind antigenic variation in pathogens

A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to evade the immune system.

Almirall partners with etherna; Daiichi’s RNA deal with Depixus; SQZ founder’s startup emerges from stealth

Plus, news on Antabio’s €25 million Series B, Athira’s Alzheimer’s data, Connect’s asthma results and Liquidia’s $25 million raise. Almirall, etherna’s new partnership: The companies

December 13, 2023

Agilent’s McDonnell to succeed retiring CEO McMullen

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Name: Padraig McDonnell New title: CEO-elect and

February 22, 2024

Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate – Biotech Investments

EQS-News: Biotest AG / Key word(s): Study results Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate 14.02.2024 / 08:30 CET/CEST The

February 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.